Here are the top 5 medtech stories of mid-2017

The middle of 2017 is shaping up to be a continued whirlwind of activity for medtech. FDA is getting used to its new leadership but is facing a continued lack of clarity on user fees and UDIs. Industry is seeing a deeper consolidation in medical supplies, exemplified in Cardinal Health’s purchase of patient recovery supplies from

Pages: 1 2 3 4 5 6

Becton Dickinson to acquire Bard in $24B deal

Becton Dickinson (NYSE:BDX) has inked an agreement with C. R. Bard (NYSE:BCR) to acquire the medtech company for $317.00 per Bard common share in cash and stock, valuing the deal at $24 billion. In announcing the deal yesterday, Franklin Lakes, N.J.-based BD said it plans to create a new segment within the company, BD Interventional, to

S&P: Medtech outlook stable, even after downgrades

The outlook for investment-grade medical device companies remains stable even after a 3-year streak of 9 consecutive downgrades, according to a new report from S&P. The downgrade of investment-grade medical device companies was mostly caused by debt-financed mergers and acquisitions, according to S&P. Factors like changes in operating performance trends and financial policy also contributed

Donald Trump: What medtech’s top executives are saying

For the most part, the medical device industry’s top executives have sounded positive about the new Trump administration and Republican Congress during recent earnings calls with analysts. Some such as Johnson & Johnson CEO Alex Gorsky have even offered advice. And while there are many open questions, top executives insist potential repeal and replace of

Pages: 1 2 3 4 5 6 7 8

Bard announces ePTFE encapsulation services for OEM customers

C.R. Bard announced today it is making its expanded polytetrafluoroethylene (ePTFE) encapsulation services available to OEM customers. Bard originally developed the ePTFE encapsulation services its own branded stents. Bard OEM customers will now have access to the material and processes needed for encapsulating their own component or device. Such ePTFE encapsulation is especially suited for